Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW, Teraphongphom N, de Boer E, van den Berg NS, Divi V, Kaplan MJ, Oberhelman NJ, Hong SS, Capes E, Colevas AD, Warram JM, Rosenthal EL. Gao RW, et al. Among authors: kaplan mj. Theranostics. 2018 Mar 28;8(9):2488-2495. doi: 10.7150/thno.24487. eCollection 2018. Theranostics. 2018. PMID: 29721094 Free PMC article. Clinical Trial.
Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
Gao RW, Teraphongphom NT, van den Berg NS, Martin BA, Oberhelman NJ, Divi V, Kaplan MJ, Hong SS, Lu G, Ertsey R, Tummers WSFJ, Gomez AJ, Holsinger FC, Kong CS, Colevas AD, Warram JM, Rosenthal EL. Gao RW, et al. Among authors: kaplan mj. Cancer Res. 2018 Sep 1;78(17):5144-5154. doi: 10.1158/0008-5472.CAN-18-0878. Epub 2018 Jul 2. Cancer Res. 2018. PMID: 29967260 Free PMC article.
Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
Nishio N, van Keulen S, van den Berg NS, Lu G, LaRochelle EP, Davis SC, Martin BA, Fakurnejad S, Zhou Q, Birkeland AC, Kaplan MJ, Divi V, Colevas AD, Pogue BW, Rosenthal EL. Nishio N, et al. Among authors: kaplan mj. Head Neck. 2020 Jan;42(1):59-66. doi: 10.1002/hed.25964. Epub 2019 Oct 1. Head Neck. 2020. PMID: 31571335
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Lee YJ, van den Berg NS, Duan H, Azevedo EC, Ferri V, Hom M, Raymundo RC, Valencia A, Castillo J, Shen B, Zhou Q, Freeman L, Koran ME, Kaplan MJ, Colevas AD, Baik FM, Chin FT, Martin BA, Iagaru A, Rosenthal EL. Lee YJ, et al. Among authors: kaplan mj. Clin Cancer Res. 2022 Oct 14;28(20):4425-4434. doi: 10.1158/1078-0432.CCR-22-0094. Clin Cancer Res. 2022. PMID: 35929985 Clinical Trial.
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
Murillo-Sauca O, Chung MK, Shin JH, Karamboulas C, Kwok S, Jung YH, Oakley R, Tysome JR, Farnebo LO, Kaplan MJ, Sirjani D, Divi V, Holsinger FC, Tomeh C, Nichols A, Le QT, Colevas AD, Kong CS, Uppaluri R, Lewis JS Jr, Ailles LE, Sunwoo JB. Murillo-Sauca O, et al. Among authors: kaplan mj. Oncotarget. 2014 Aug 30;5(16):6854-66. doi: 10.18632/oncotarget.2269. Oncotarget. 2014. PMID: 25149537 Free PMC article.
393 results